Insider · CIK 0001596057
Kevin Kennedy Brown
Files at SNBRQ (Sleep Number Corp). First filing -, latest -.
In brief
Kevin Kennedy Brown files SEC Form 4 as officer at SNBRQ (Sleep Number Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kevin Kennedy Brown has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 11, 2025 | SNBRQ Sleep Number Corp | 47,573 0.21% of outstanding | $418k | Jun 11, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2025 | SNBRQ Sleep Number Corp | AGrant or award Common Stock | +24,439 | $0.00 | $0 | 80,335 | Mar 17, 2025 |
Questions about Kevin Kennedy Brown
Answered from the filings on this page, as of the latest one.
Is Kevin Kennedy Brown buying or selling?
Kevin Kennedy Brown has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kevin Kennedy Brown's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Kennedy Brown has 0.
Where does Kevin Kennedy Brown file Form 4?
Kevin Kennedy Brown has filed Form 4 at SNBRQ (Sleep Number Corp) as EVP and CMO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.